Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


17 Items
Title  Creator  Group name  Publishing year 
The organizer of chromatin topology RIF1 ensures cellular resilience to DNA replication stress Lebdy et al. PlateformePP2I 2023-04
Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells Denis et al. PlateformePP2I 2022
IgG3 donor-specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantation Pernin et al. PlateformePP2I 2021-12-04
Distribution of de novo Donor-Specific Antibody Subclasses Quantified by Mass Spectrometry: High IgG3 Proportion Is Associated With Antibody-Mediated Rejection Occurrence and Severity Pernin et al. PlateformePP2I 2020
Chemical composition and selective BuChE inhibitory activity of the essential oils from aromatic plants used to prepare the traditional Ecuadorian beverage horchata lojana Armijos et al. EquipePM Jul 28, 2020
An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresis Dadouch et al. EquipePM Jan 08, 2020
Proteasome 19S RP and translation preinitiation complexes are secreted within exosomes upon serum starvation Bec et al. EquipePM May 01, 2019
Chemical, Enantioselective, and Sensory Analysis of a Cholinesterase Inhibitor Essential Oil from Coreopsis triloba S.F. Blake (Asteraceae) Espinosa et al. EquipePM Oct 25, 2019
Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling Kumbhar et al. EquipePM Jun 2018
Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity Courbet et al. EquipePM 2017
Acorenone B: AChE and BChE Inhibitor as a Major Compound of the Essential Oil Distilled from the Ecuadorian Species Niphogeton dissecta (Benth.) J.F. Macbr Calva et al. EquipePM Oct 31, 2017
New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships Zghaib et al. PlateformePP2I 06 01, 2016
Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks Ribeyre et al. PlateformePP2I Apr 12, 2016
Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity Bastid et al. PlateformePP2I Mar 2015
Systemic delivery of P42 peptide: a new weapon to fight Huntington's disease Arribat et al. PlateformePP2I Aug 05, 2014
In-cell intrabody selection from a diverse human library identifies C12orf4 protein as a new player in rodent mast cell degranulation Mazuc et al. PlateformePP2I 2014
Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor Bianga et al. PlateformePP2I Aug 2014
17 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés